Selective inhibition of mandibular growth and induction of cleft palate by diazo-oxo-norleucine (DON) in the rat.
A high percentage of cleft palates can be induced in rat fetuses by a single injection of the glutamine analog diazo-oxo-norleucine (DON) on day 15 of gestation. The purpose of this study was to evaluate the effects of DON in vivo on craniofacial growth and spatial relations in order to identify factors that may contribute to the palatal defects. Sprague-Dawley rats in the experimental groups were given a single IP injection of 2.0 mg DON (6 mg/kg maternal body weight) on day 15 and were killed on day 16 or 17. Control fetuses were collected on days 15, 16 and 17. Fetal heads were fixed in Bouin's solution, embedded in Paraplast and serially-sectioned. Midsagittal and coronal sections were projected at 30 X and a series of linear and angular measurements were made. DON had limited effect on growth of the cranial base, nasomaxillary complex, and palatine processes, but dramatically reduced the length of Meckel's cartilage. Treatment with DON delayed shelf elevation approximately 24 hours, and tongue position remained high in the oronasal cavity. Growth retardation in Meckel's cartilage therefore may contribute to delayed shelf movement by retarding downward and forward positioning of the tongue-mandibular complex.
D000818:Animals; D001391:Azo Compounds; D002972:Cleft Palate / Q000139:chemically induced* / Q000473:pathology; D003980:Diazooxonorleucine; D005260:Female; D008334:Mandible / Q000196:embryology; D008445:Maxillofacial Development / Q000187:drug effects*; D011247:Pregnancy; D051381:Rats; D014059:Tongue / Q000196:embryology
D001391:Azo Compounds; D003980:Diazooxonorleucine